The presence of a long history of alcohol abuse in patients with cognitive decline may be a problem in the differential diagnosis, especially when dealing with elderly patients, where Alzheimer's disease (AD) is the most frequent cause of dementia. Since specific treatments are now available for AD, while the effect of alcohol on cognition may be reversible to some extent, the need for early discrimination between the two disorders is obvious.
Cerebrospinal fluid (CSF) markers including tau protein, amyloid Aβ42 and their ratio received much attention recently, since they may be of some help in the diagnosis of AD and the differential diagnosis from other causes of dementia, in terms of every-day practice. In the differential diagnosis of AD from alcohol-related cognitive decline CSF tau is better than Aβ42 alone. In a patient with cognitive decline and history of alcohol abuse increased levels of CSF tau almost confirm the (co)existence of AD at all levels of clinical confidence. However, normal CSF tau levels do not always exclude AD. The combined use of tau with Aβ42 in the form of their ratio (tau/Aβ42) resolves the problem. An increased ratio almost confirms the (co)existence of AD, with a positive predictive value that may approach or even exceed 99% at all levels of clinical (pre-test) confidence, while a normal ratio almost excludes the (co)existence of AD, with a negative predictive value > 90% at all levels of clinical confidence. The discriminating value is comparable in patient with early cognitive decline (MMSE > 23) or more advanced disease.
The method required for the determination of tau and Aβ42 is an ELISA method, which is easy to perform and does not require ionizing radiation, specially trained personnel and expensive equipment. Lumbar puncture is a minimally to moderately invasive procedure, but usually well tolerated and safe, provided that there is no contraindication. The incidence of post-lumbar puncture headache is low in the elderly population and probably no more than 5.5%. Given the above, the determination of CSF markers of AD may be helpful in the every-day diagnostic work-up of elderly demented patients with a history of alcohol abuse. <supplement> <title> <p>International Society on Brain and Behaviour: 2nd International Congress on Brain and Behaviour</p> </title> <note>Meeting abstracts -A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1744-859X-5-S1-full.pdf">here</a>.</note> </supplement>
